U.S. FDA approved EmrosiTM (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the <a target=_blank href= ...

QUESTION: I have suffered from acne and rosacea since I was a teenager. Back then, my dermatologist recommended benzoyl ...

Drug shortages have become a significant barrier in healthcare, impacting patients with a variety of chronic and acute conditions who rely on timely access to medications. Prescription Quest ...

Dermatology drugmaker Journey Medical has trekked its Dr. Reddy’s Laboratories-partnered rosacea med across the FDA finish line as Emrosi. The drug was cleared to treat inflammatory lesions of ...

The dark skies during a new moon provide ideal conditions for spotting skywatching targets that would otherwise be outshined by moonlight. The next new moon will occur on Sunday, Dec. 1 at 1:21 a ...

Opens in a new tab or window The FDA approved minocycline hydrochloride extended-release capsules (Emrosi) for treating inflammatory lesions of rosacea in adults, drugmaker Journey Medical ...

you can take medications that reduce the number of future headaches (preventive treatment). An over-the-counter (OTC) pain reliever may ease mild to moderate migraines but can't prevent them. Some ...

We’re both over 65 and already had signed up for Medicare, but suddenly we had to consider picking a Medicare Part D plan for prescription drugs. KFF reports that at least 53 million Americans ...

Doctors with Calissa Therapeutics are trying to get the new treatment to come to the U.S., as patients in China have seen positive results.

New Yorkers may be eligible for compensation ... reduce competition and restrict trade for several generic prescription drugs. Some of the involved companies increased prices by 1,000% and the ...